Program
Amlodipine
Also written as “amlodipine”, “Amlodipine 5 mg” and “Amlodipine 10 mg”.
Its studies are mostly in Hypertension · Essential Hypertension · Hyperlipidemias · Kidney Diseases · Hypercholesterolemia, led by 35 companies.
Drug pageAmlodipine: every studyMany companies study it; this page follows only the 170 they lead. All 284 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novartis | 570 open or running | phase 4since Aug 25, 2005 | Aug 25, 2005 | none ahead |
| Boehringer Ingelheimits history only | 220 open or running | phase 4since Oct 14, 2005 | Oct 14, 2005 | none ahead |
| Viatrisits history only | 130 open or running | phase 4since Aug 31, 2005 | Aug 31, 2005 | none ahead |
| Hanmi Pharmaceuticalits history only | 110 open or running | phase 3since Jul 14, 2009 | Jul 14, 2009 | none ahead |
| Dr. Reddy's Laboratoriesits history only | 80 open or running | phase 1since May 26, 2010 | May 26, 2010 | none ahead |
| HK inno.Nits history only | 50 open or running | phase 3since Feb 16, 2015 | Feb 10, 2014 | none ahead |
| Handokits history only | 40 open or running | phase 3since Jul 24, 2022 | Jul 21, 2020 | none ahead |
| Teva Pharmaceutical Industriesits history only | 40 open or running | phase 1since Feb 9, 2009 | Feb 9, 2009 | none ahead |
| Yuhanits history only | 41 open or running | phase 4since Sep 4, 2023 | May 29, 2014 | none ahead |
| Chong Kun Dang Pharmaceuticalits history only | 30 open or running | phase 3since Jan 8, 2016 | Feb 14, 2014 | none ahead |
| Daewoong Pharmaceuticalits history only | 30 open or running | phase 3since Dec 12, 2016 | Mar 4, 2013 | none ahead |
| IlDong Pharmaceuticalits history only | 30 open or running | phase 3since Apr 11, 2016 | Mar 31, 2016 | none ahead |
| Merckits history only | 30 open or running | phase 3since Feb 22, 2011 | Nov 10, 2008 | none ahead |
| Daewon Pharmaceuticalits history only | 20 open or running | phase 3since Oct 12, 2016 | Oct 12, 2016 | none ahead |
| Hikma Pharmaceuticalsits history only | 20 open or running | no phasesince Jan 15, 2008 | Jan 15, 2008 | none ahead |
| Jeil Pharmaceuticalits history only | 20 open or running | phase 1since Mar 9, 2015 | Mar 9, 2015 | none ahead |
| Menarini Groupits history only | 20 open or running | phase 4since Mar 4, 2022 | Mar 4, 2022 | none ahead |
| Midas Pharmaits history only | 20 open or running | phase 1since Jan 23, 2020 | Jan 23, 2020 | none ahead |
| Sun Pharmaceutical Industriesits history only | 20 open or running | no phasesince Oct 16, 2008 | Oct 16, 2008 | none ahead |
| Torrent Pharmaceuticalsits history only | 20 open or running | phase 1since Jul 1, 2009 | Jul 1, 2009 | none ahead |
| TSH Biopharmits history only | 20 open or running | phase 4since Jun 15, 2011 | Jun 15, 2011 | none ahead |
| Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratoriesits history only | 10 open or running | phase 1since Mar 10, 2016 | Mar 10, 2016 | none ahead |
| Celltrionits history only | 10 open or running | phase 3since Apr 27, 2026 | Apr 27, 2026 | none ahead |
| Genuine Research Center, Egyptits history only | 10 open or running | phase 1since Jul 30, 2015 | Jul 30, 2015 | none ahead |
| Hyundai Pharmits history only | 11 open or running | phase 3since Oct 15, 2024 | Oct 15, 2024 | none ahead |
| InVasc Therapeuticsits history only | 10 open or running | phase 4since Jan 5, 2011 | Jan 5, 2011 | none ahead |
| Kitov Pharmaceuticalsits history only | 10 open or running | phase 3since Jun 20, 2014 | Jun 20, 2014 | none ahead |
| Lotus Pharmaceuticalits history only | 10 open or running | phase 1since May 23, 2016 | May 23, 2016 | none ahead |
| Organonits history only | 10 open or running | phase 4since Aug 30, 2005 | Aug 30, 2005 | none ahead |
| Pfizerits history only | 10 open or running | phase 3since Mar 2, 2007 | Mar 2, 2007 | none ahead |
| Servierits history only | 10 open or running | phase 3since Feb 25, 2022 | Feb 25, 2022 | none ahead |
| Shanghai Haini Pharmaceuticalits history only | 10 open or running | phase 1since Nov 17, 2016 | Nov 17, 2016 | none ahead |
| Shin Poong Pharmaceuticalits history only | 10 open or running | phase 2since Oct 24, 2016 | Oct 24, 2016 | none ahead |
| Takedaits history only | 10 open or running | phase 3since Nov 17, 2016 | Nov 17, 2016 | none ahead |
| Zentiva, k.s.its history only | 11 open or running | phase 3since May 25, 2026 | May 25, 2026 | Dec 31, 2027phase 3 · NCT07618806 |
Also a collaborator on its studies: CSPC Pharmaceutical Group and Integrium.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Novartis only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 42 studies since Aug 25, 2005.
- Nov 24, 2008Phase 3 study in HypertensionNCT00797862 · 1,254 enrolled · Canada, Costa Rica, France and more
- Feb 10, 2009Phase 3 study in HypertensionNCT00841672 · 485 enrolled · Germany, Philippines, Romania and more
- Feb 26, 2009Phase 4 study in HypertensionNCT00853957 · 443 enrolled · United States
- Apr 28, 2009Phase 4 study in HypertensionNCT00902304 · 2,337 enrolled · United States, Australia
- Jul 1, 2009Phase 4 study in Isolated Systolic HypertensionNCT00931710 · 488 enrolled · United States
- Oct 15, 2009Phase 3 study in Essential HypertensionNCT01001572 · 932 enrolled
- Feb 6, 20102 phase 4 studies in HypertensionNCT01070043, NCT01070030
- Mar 3, 2010Phase 2 study in HypertensionNCT01080768 · 31 enrolled · Netherlands
- Apr 27, 2010Phase 3 study in Essential HypertensionNCT01113047 · 347 enrolled · Germany
- Jul 20, 2010Phase 4 study in HypertensionNCT01167153 · 564 enrolled · China
- Oct 29, 2010Phase 3 study in Essential HypertensionNCT01237223 · 1,342 enrolled · Japan
- Nov 15, 2010Phase 4 study in Essential HypertensionNCT01241487 · 150 enrolled · Egypt
- Dec 10, 2010Phase 3 study in Cardiovascular EventsNCT01259297 · 2,336 enrolled · United States, Argentina, Brazil and more
- Feb 12, 2014Phase 4 study in Essential HypertensionNCT02062645 · 115 enrolled · Turkey
TargetBeta
“Voltage-gated L-type calcium channel blocker; Voltage-gated L-type calcium channel blocker; Voltage-gated L-type calcium channel blocker”ChEMBL 37, by rule
Other programs on the same 4 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Pregabalinrule | Viatris | phase 4 | 149 |
| Gabapentinrule | Viatris | phase 4 | 49 |
| Dronedaronerule | Sanofi | phase 4 | 18 |
| Nifedipinerule | Bayer | phase 4 | 18 |
Studies
All 57 Novartis leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02062645Essential Hypertension · Turkey | 4 | Completed | Sep 2015 | 115 |
| NCT01259297Cardiovascular Events · United States, Argentina, Brazil and more | 3 | Terminated | Nov 2012 | 2,336 |
| NCT01241487Essential Hypertension · Egypt | 4 | Completed | Jan 2011 | 150 |
| NCT01237223Essential Hypertension · Japan | 3 | Completed | May 2011 | 1,342 |
| NCT01167153Hypertension · China | 4 | Completed | Apr 2011 | 564 |
| NCT01113047Essential Hypertension · Germany | 3 | Completed | Oct 2010 | 347 |
| NCT01080768Hypertension · Netherlands | 2 | Terminated | Nov 2010 | 31 |
| NCT01070030Hypertension · Thailand | 4 | Completed | Oct 2010 | 230 |
| NCT01070043Hypertension · Taiwan | 4 | Completed | Sep 2010 | 60 |
| NCT01001572Essential Hypertension | 3 | Completed | May 2010 | 932 |
| NCT00931710Isolated Systolic Hypertension · United States | 4 | Completed | Jan 2010 | 488 |
| NCT00902304Hypertension · United States, Australia | 4 | Completed | Jul 2011 | 2,337 |
| NCT00853957Hypertension · United States | 4 | Completed | Aug 2009 | 443 |
| NCT00841672Hypertension · Germany, Philippines, Romania and more | 3 | Completed | Sep 2009 | 485 |
| NCT00797862Hypertension · Canada, Costa Rica, France and more | 3 | Completed | Nov 2010 | 1,254 |
| NCT00778921Hypertension · Argentina, Germany, Norway and more | 3 | Completed | Jun 2009 | 847 |
| NCT00777946Hypertension · Estonia, France, Iceland and more | 3 | Completed | May 2009 | 818 |
| NCT00765674Hypertension · United States, Australia, Canada and more | 3 | Completed | Aug 2009 | 1,191 |
| NCT00739973Hypertension · United States, Argentina, Australia and more | 3 | Completed | May 2009 | 2,694 |
| NCT00667719Essential Hypertension · United States, Belgium, Egypt and more | 3 | Completed | Oct 5, 2009 | 564 |
| NCT00666536Hypertension · United States | 4 | Completed | Jan 2009 | 728 |
| NCT00687973Hypertension · France | 4 | Completed | Jan 2009 | 393 |
| NCT00700271Hypertension · France, Tunisia | 4 | Completed | Aug 2008 | 478 |
| NCT00548067Hypertension · India | 3 | Completed | 111 | |
| NCT00523744Hypertension · Germany | 3 | Completed | Dec 2007 | 257 |
| NCT00523549Hypertension · United States | 4 | Completed | Jan 2008 | 229 |
| NCT00446563Hypertension · Germany | 3 | Completed | Mar 2010 | 90 |
| NCT00446524Hypertension · Japan | 3 | Completed | Oct 2008 | 403 |
| NCT00437645Essential Hypertension · Argentina, Chile, Ecuador and more | 3 | Completed | Nov 2007 | 1,183 |
| NCT00426478Hypertension · Taiwan | 4 | Completed | 80 | |
| NCT00425997Hypertension · United States | 4 | Completed | Oct 2007 | 480 |
| NCT00425373Essential Hypertension · Japan | 3 | Completed | Mar 2008 | 1,474 |
| NCT00413413Hypertension · China | 3 | Completed | Nov 2007 | 1,134 |
| NCT00413049Hypertension · China | 3 | Completed | Nov 2007 | 698 |
| NCT00409851Hypertension · United States, Germany | 3 | Completed | Mar 2005 | 1,293 |
| NCT00409760Hypertension · Germany | 3 | Completed | Feb 2004 | 1,930 |
| NCT00409643Hypertension · United States, Germany | 3 | Completed | Jul 2004 | 1,259 |
| NCT00402103Hypertension · United States, Belgium, Denmark and more | 3 | Completed | Apr 2008 | 556 |
| NCT00400777Hypertension · Brazil | 4 | Completed | Nov 2007 | 460 |
| NCT00392262Hypertension · Germany, Switzerland | 3 | Completed | Feb 2007 | 224 |
| NCT00367978Hypertension · United States | 4 | Completed | Sep 2003 | 275 |
| NCT00367939Hypertension · Germany | 3 | Completed | Jul 2006 | 132 |
| NCT00353912Hypertension · United States | 3 | Completed | Apr 2007 | 571 |
| NCT00350168Hypertension · United States | 3 | Completed | Apr 2007 | 647 |
| NCT00327587Hypertension · United States | 3 | Completed | Aug 2007 | 2,279 |
| NCT00327145Hypertension · Switzerland | 3 | Completed | Jan 2007 | 894 |
| NCT00351130Hypertension · Germany, Switzerland | 4 | Completed | Mar 2007 | 79 |
| NCT00304226Hypertension · Germany, Switzerland | 4 | Completed | Jan 2007 | 1,288 |
| NCT00171535Hypertension · United States | 3 | Completed | Apr 2005 | 130 |
| NCT00171366Hypertension · United States | 3 | Completed | Jul 2005 | 1,422 |
| NCT00171054Hypertension · Switzerland | 4 | Completed | Oct 2007 | 125 |
| NCT00171002Hypertension · Germany, Switzerland | 3 | Completed | Jun 2005 | 936 |
| NCT00170976Hypertension · Germany, Switzerland | 3 | Completed | Jun 2005 | 403 |
| NCT00170963Hypertension · Germany, Switzerland | 3 | Completed | Jun 2005 | 1,018 |
| NCT00170950Hypertension · United States, Denmark, Finland and more | 3 | Terminated | Jan 2008 | 11,506 |
| NCT00139555Hypertension · United States | 4 | Completed | Nov 2006 | 125 |
| NCT00136773Albuminuria | 4 | Completed | Oct 2005 | 332 |
How it is read
Names in the registry
- “Amlodipine”, 44 entries
- “amlodipine”, 14 entries
- “Amlodipine 5 mg”, 9 entries
- “Amlodipine 10 mg”, 6 entries
- “valsartan + amlodipine”, 5 entries
Conditions, from the studies’ own filings
- Hypertension, 119 studies
- Essential Hypertension, 32 studies
- Hyperlipidemias, 3 studies
- Kidney Diseases, 1 study
- Hypercholesterolemia, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.